• Machine Learning Model for Predicting Mortality Risk in Patients With Complex Chronic Conditions: Retrospective Analysis

  Hernández Guillamet, Guillem; Morancho Pallaruelo, Ariadna Ning; Miró Mezquita, Laura; Miralles, Ramón; Mas, Miquel Àngel; Ulldemolins Papaseit, María José; Estrada Cuxart, Oriol; López Seguí, Francesc (JMIR Publications, 2023)

  Background: The health care system is undergoing a shift toward a more patient-centered approach for individuals with chronic and complex conditions, which presents a series of challenges, such as predicting hospital needs ...
• Characterization and Identification of Variations in Types of Primary Care Visits Before and During the COVID-19 Pandemic in Catalonia: Big Data Analysis Study

  López Seguí, Francesc; Hernández Guillamet, Guillem; Pifarré Arolas, Héctor; Marin Gómez, F. Xavier; Ruiz Comellas, Anna; Ramirez Morros, Anna Maria; Adroher Mas, Cristina; Vidal Alaball, Josep (JMIR Publications, 2021)

  Background: The COVID-19 pandemic has turned the care model of health systems around the world upside down, causing the abrupt cancellation of face-to-face visits and redirection of the model toward telemedicine. Digital ...
• Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study

  Tabernero, Josep; Hoff, Paulo M.; Shen, Lin; Ohtsu, Atsushi; Shah, Manish A.; Cheng, Karen; Song, Chunyan; Wu, Haiyan; Eng-Wong, Jennifer; Kim, Katherine; Kang, Yoon-Koo (Elsevier, 2018)

  Background: Adding pertuzumab to trastuzumab and chemotherapy improves survival in HER2-positive early breast cancer and metastatic breast cancer. We assessed the efficacy and safety of pertuzumab versus placebo in combination ...
• Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines

  Grothey, Axel; Fakih, Marwan; Tabernero, Josep (Elsevier, 2021)

  Colorectal cancer (CRC) is still a leading cause of cancer-related deaths in the United States and worldwide, despite recent improvements in cancer management. CRC, like many malignancies, is a heterogeneous disease, ...
• Current developments in gastric cancer: from molecular profiling to treatment strategy

  Alsina, Maria; Arrazubi, Virginia; Diez, Marc; Tabernero, Josep (SpringerNature, 2023)

  Gastric cancer and gastro-oesophageal junction cancer represent a global health-care challenge. Despite the efficacy of improved chemotherapy and surgical options, these patients still have a poor prognosis. In advanced ...

Veure tots els documents